Optimind Pharma Balance Sheet

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 31, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Cash & Equivalents	0.12	0.08	0.03	0.55	1.35
Cash & Short-Term Investments	0.12	0.08	0.03	0.55	1.35
Cash Growth	35.05%	191.94%	-94.80%	-59.16%	-
Accounts Receivable	0.04	0.04	0.02	0.03	-
Other Receivables	-	0.03	0.14	0.08	0
Receivables	0.04	0.07	0.16	0.12	0
Restricted Cash	-	-	-	-	0.51
Total Current Assets	0.16	0.15	0.19	0.67	1.86
Property, Plant & Equipment	-	-	-	0.09	0.12
Long-Term Investments	0.05	0.05	0.05	0.05	0.31
Goodwill	-	-	-	-	0.86
Other Intangible Assets	-	-	-	0.37	0.66
Total Assets	0.21	0.2	0.24	1.35	3.82
Accounts Payable	0.16	0.15	0.24	0.09	0.13
Short-Term Debt	0.12	0.13	0.13	0.5	-
Current Portion of Leases	-	-	-	0.03	0.02
Other Current Liabilities	-	-	-	-	0.51
Total Current Liabilities	0.28	0.27	0.37	0.62	0.66
Long-Term Leases	-	-	-	0.08	0.11
Long-Term Deferred Tax Liabilities	-	-	-	0.01	0
Total Liabilities	0.29	0.27	0.37	0.71	0.78
Common Stock	4.8	4.79	4.52	4.02	3.39
Additional Paid-In Capital	0.01	0.01	0.01	0.04	-
Retained Earnings	-5.05	-5.04	-4.82	-3.43	-0.35
Comprehensive Income & Other	0.16	0.16	0.16	-	-
Shareholders' Equity	-0.08	-0.07	-0.13	0.64	3.04
Total Liabilities & Equity	0.21	0.2	0.24	1.35	3.82
Total Debt	0.12	0.13	0.13	0.61	0.13
Net Cash (Debt)	0	-0.04	-0.1	-0.06	1.22
Net Cash Per Share	0.00	-0.00	-0.00	-0.00	0.03
Filing Date Shares Outstanding	103.15	103.15	116.89	97.93	43.59
Total Common Shares Outstanding	103.15	109.79	116.89	97.93	43.59
Working Capital	-0.13	-0.12	-0.18	0.04	1.2
Book Value Per Share	-0.00	-0.00	-0.00	0.01	0.07
Tangible Book Value	-0.08	-0.07	-0.13	0.27	1.52
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.00	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.